Argomenti e Notizie
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Anno 19°
Num. 124
Recens. 2395
Aderiamo allo standard HONcode per l'affidabilità dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
 ?      Auguri a tutti i visitatori di questo sito!
Nuova bibliografia selezionata fino al mese di ottobre 2014 (recensioni 18) Ordina per Autore - Titolo - Rivista
Bolland MJ, Grey A.
A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record.
BMJ Open. 2014 Oct 7;4(10):e005787.

Unni S, Yao Y, Milne N, Gunning K, Curtis JR, LaFleur J.
An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database.
Osteoporos Int. 2014 Oct 7. [Epub ahead of print]

Reginster JY.
Cardiac concerns associated with strontium ranelate.
Expert Opin Drug Saf. 2014 Sep;13(9):1209-13.

Frediani B, Baraldi E, Cremonesi G.
Effect of clodronate treatment on risk of fracture: a systematic review and meta-analysis.
Calcif Tissue Int. 2014 Oct;95(4):295-307.

Kremer R, Gagnon B, Meguerditchian AN, Nadeau L, Mayo N.
Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.
J Natl Cancer Inst. 2014 Oct 2;106(11).

Takahashi N, Arai I, Kayama S, Ichiji K, Fukuda H, Handa JI, Konno SI.
Fukushima J Med Sci. 2014 Oct 4.

Byberg L, Bellavia A, Orsini N, Wolk A, Michaëlsson K.
Fruit and vegetable intake and risk of hip fracture: A cohort study of Swedish men and women.
J Bone Miner Res. 2014 Oct 7.

Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y.
Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
J Bone Miner Metab. 2014 Sep 17.

Reid R, Abramson BL, Blake J, Desindes S, Dodin S, Johnston S, Rowe T, Sodhi N, Wilks P, Wolfman W; Menopause And Osteoporosis Working Group, Fortier M, Reid R, Abramson BL, Blake J, Desindes S, Dodin S, Graves L, Guthrie B, Khan A, Johnston S, Rowe T, Sodhi N, Wilks P, Wolfman W.
Managing menopause.
J Obstet Gynaecol Can. 2014 Sep;36(9):830-3.

Wilk A, Sajjan S, Modi A, Fan CP, Mavros P.
Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA.
Osteoporos Int. 2014 Dec;25(12):2777-86.

Amorim T, Wyon M, Maia J, Machado JC, Marques F, Metsios GS, Flouris AD, Koutedakis Y.
Prevalence of Low Bone Mineral Density in Female Dancers.
Sports Med. 2014 Oct 4.

Gabbert TI, Hoffmeister B, Felsenberg D.
Risk factors influencing the duration of treatment with bisphosphonates until occurrence of an osteonecrosis of the jaw in 963 cancer patients.
J Cancer Res Clin Oncol. 2014 Oct 16.

Bao X, Liu X, Zhang Y, Cui Y, Yao J, Hu M.
Strontium promotes cementoblasts differentiation through inhibiting sclerostin expression in vitro.
Biomed Res Int. 2014;2014:487535.

Kirschneck C, Wolf M, Reicheneder C, Wahlmann U, Proff P, Roemer P.
Strontium ranelate improved tooth anchorage and reduced root resorption in orthodontic treatment of rats.
Eur J Pharmacol. 2014 Sep 30. pii: S0014-2999(14)00695-5.

Liu X, Zhu S, Cui J, Shao H, Zhang W, Yang H, Xu Y, Geng D, Yu L.
Strontium ranelate inhibits titanium-particle-induced osteolysis by restraining inflammatory osteoclastogenesis in vivo.
Acta Biomater. 2014 Nov;10(11):4912-8.

Holick MF.
Sunlight, ultraviolet radiation, vitamin D and skin cancer: how much sunlight do we need?
Adv Exp Med Biol. 2014;810:1-16. Review.

Kancherla VK, Nwachuku CO.
The treatment of periprosthetic femur fractures after total knee arthroplasty.
Orthop Clin North Am. 2014 Oct;45(4):457-67. Review.

Ishtiaq S, Fogelman I, Hampson G.
Treatment of post-menopausal osteoporosis: beyond bisphosphonates.
J Endocrinol Invest. 2014 Sep 7.

(Vers. 2.1)  Modificato il 9-11-2014   
questo sito aderisce ai principi HONCODE    disclaimer